소아 키 성장에 미치는 한삼덩굴추출분말의 유효성 및 안전성을 평가하기 위한 무작위배정, 이중눈가림, 위약 대조 인체적용시험: 인체적용시험 프로토콜
Randomized, Double-blind, and Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Humulus japonicus Extract Powder on Child Height Growth: Study Protocol
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives We aimed to confirm whether Humulus japonicus Extract Powder can enhance child height growth significantly and safely compared with a placebo. Methods A total of 150 children between the 3rd and 25th percentiles in height and between the ages of 6 and 9 years will be recruited to participate in this randomized, double-blind, placebo-controlled clinical trial. The participants will be randomly assigned to the treatment or placebo group. Participants in the treatment group will take one pack per day (700 mg of Humulus japonicus Extract Powder) for 24 weeks. Participants in the placebo group will take one package of placebo per day (0 mg of Humulus japonicus Extract Powder) for 24 weeks. The primary outcome will be a change in height after 12 weeks, and the secondary outcomes will be the height after 24 weeks, growth rate, height standard deviation, growth hormone, insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), bone alkaline phosphatase (BALP), and osteocalcin after 12 and 24 weeks. Results This protocol was approved by the Institutional Review Board (IRB) of the Korean Medicine Hospital of Busan University (IRB No. PNUKHIRB-2023-03-002). Research participants will be recruited from June 2023 to December 2023. Conclusions The results of this study provide clinical information regarding the effectiveness and safety of the Humulus japonicus Extract Powder in increasing child height.
Abstract
Objectives We aimed to confirm whether Humulus japonicus Extract Powder can enhance child height growth significantly and safely compared with a placebo. Methods A total of 150 children between the 3rd and 25th percentiles in height and between the ages of 6 and 9 years will be recruited to participate in this randomized, double-blind, placebo-controlled clinical trial. The participants will be randomly assigned to the treatment or placebo group. Participants in the treatment group will take one pack per day (700 mg of Humulus japonicus Extract Powder) for 24 weeks. Participants in the placebo group will take one package of placebo per day (0 mg of Humulus japonicus Extract Powder) for 24 weeks. The primary outcome will be a change in height after 12 weeks, and the secondary outcomes will be the height after 24 weeks, growth rate, height standard deviation, growth hormone, insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), bone alkaline phosphatase (BALP), and osteocalcin after 12 and 24 weeks. Results This protocol was approved by the Institutional Review Board (IRB) of the Korean Medicine Hospital of Busan University (IRB No. PNUKHIRB-2023-03-002). Research participants will be recruited from June 2023 to December 2023. Conclusions The results of this study provide clinical information regarding the effectiveness and safety of the Humulus japonicus Extract Powder in increasing child height.
참고문헌 (53)
- 임영권, "성장기 소아청소년들의 이차성징에 따른 진맥시 맥박변화와 골연령, 역연령, 키, 체중 등의 상관성 연구", 대한한의학회지, 35(1), pp.88~98 (2014), 대한한의학회
- Nam HK, "Approach to short stature in children and adolescent", Ewha Med J, 44(4), pp.111~116 (2021)
- 성인경, "일차진료에서 소아청소년의 성장 평가", 대한의사협회지, 52(3), pp.211~224 (2009), 대한의사협회
- Korean Society of Pediatric Endocrinology, "Pediatric Endocrinology", pp.83~92 (2020), Koonja
- 이유진, "소아 성장을 위한 한약 투여에 대한 임상적 연구", 대한한방소아과학회지, 25(1), pp.49~62 (2011), 대한한방소아과학회
- 이기형, "약물요법", 저신장 소아의 성장호르몬 치료, 2008, pp.51(9), 849~855[DOI]
- 장수빈, "소아 성장 한의약건강증진프로그램 개발", 대한예방한의학회지, 26(1), pp.1~10 (2022), 대한예방한의학회[DOI]
- Kemp SF, "Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature", J Clin Endocrinol Metab, 90(9), pp.5247~5253 (2005)
- Stefano Cianfarani, "Risk of cancer in patients treated with recombinant human growth hormone in childhood", Annals of Pediatric Endocrinology & Metabolism, 24(2), pp.92~98 (2019), 대한소아내분비학회[DOI]
- Shin MK, "Clinical Traditional Herbalogy", pp.449~450 (1997), Younglimsa
- Heo JY, "Chemical components of Humulus japonicus leaves and stalks", J Agric Life Sci, 37(1), pp.1~7 (2003)
- Lim DB, "The Effect of Humulus japonicus on analgesia, anti-inflammation, and urination", Kor J Herbology, 8(1), pp.69~75 (1993)
- 정윤희, "Aqueous Extract of Humulus japonicus Attenuates Hyperlipidemia and Fatty Liver in Obese Mice", Journal of Medicinal Food, 21(10), pp.999~1008 (2018), 한국식품영양과학회[DOI]
- Park SW, "Antimicrobial and antioxidative activities of solvent fraction from Humulus japonicus", Korean J Food Sci Technol, 26(4), pp.464~470 (1994)
- 황순이, "葎草가 항염 효과에 미치는 영향", 한방안이비인후피부과학회지, 22(2), pp.92~103 (2009), 대한한방안이비인후피부과학회
- Lee YR, "Antioxidant and antitumor activities of methanolic extract form Humulus japonicus", Korean J Food Sci Technol, 25(2), pp.357~361 (2012)
- Heo J, "A New Translation Donguibogam", pp.769~3565 (2005), Bubin Publishing Co
- Kim OK, "A Mixture of Humulus japonicus increases longitudinal bone growth rate in Sprague Dawley rats", Nutrients, 12(9), pp.2625~ (2020)
- 김옥경, "Effects of a Mixture of Humulus japonicus on Longitudinal Bone Growth in Hypophysectomized Rats", Journal of Medicinal Food, 24(5), pp.497~504 (2021), 한국식품영양과학회[DOI]
- 김재현, "The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects", Clinical and Experimental Pediatrics, 61(5), pp.135~149 (2018), 대한소아청소년과학회
- Ra JC, "The development of functional food with plant extracts for enhancing growth rate", J Food Hyg Saf, 19(3), pp.112~118 (2004)
- "Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers" (2018)[URL]
- "Can Program Introduction" (2015)[URL]
- 이영준, "소아에서 성장호르몬 대사 효과", Journal of Obesity & Metabolic Syndrome, 24(2), pp.87~91 (2015), 대한비만학회
- Ahn HS, "Hong Changui Pediatrics", pp.13~9897 (2008), Mirae N
- Rogol AD, "Etiologies and early diagnosis of short stature and growth failure in children and adolescents", J Pediatr, 164(5 Suppl), pp.S1~S14 (2014)
- Nella Polidori, "Deciphering short stature in children", Annals of Pediatric Endocrinology & Metabolism, 25(2), pp.69~79 (2020), 대한소아내분비학회[DOI]
- Lindsay R, "Utah Growth Study : growth standards and the prevalence of growth hormone deficiency", J Pediatr, 125(1), pp.29~35 (1994)
- Shiva S, "Etiology of short stature in East Azerbaijan, Iran", Iran J Pediatr, 19(1), pp.35~40 (2009)
- Seok Eun mi, "Effectiveness of growth hormone therapy in children with Noonan syndrome", Annals of Pediatric Endocrinology & Metabolism, 25(3), pp.182~186 (2020), 대한소아내분비학회[DOI]
- Ranke MB, "Growth hormone-past, present and future", Nat Rev Endocrinol, 14(5), pp.285~300 (2018)
- 김지은, "소아 성장을 위한 한약 투여에 대한 후향적 연구", 대한한방소아과학회지, 30(4), pp.87~98 (2016), 대한한방소아과학회
- 한지은, "소아 성장에 대한 한의학 치료: 국내 임상연구에 대한 문헌적 고찰", 대한한방소아과학회지, 35(1), pp.18~29 (2021), 대한한방소아과학회
- 권지현, "국내 소아성장 한약치료에 대한 고찰", 대한한방소아과학회지, 32(4), pp.103~112 (2018), 대한한방소아과학회[DOI]
- Department of Pediatrics, Nationwide Korean Medicine College, "Pediatrics of Korean Medicine", pp.814~817 (2020), Ui Sung Dang Publishing Co
- 박슬기, "소아 성장의 침구 및 수기요법에 대한 중의학 임상 연구 고찰", 대한한방소아과학회지, 33(1), pp.58~77 (2019), 대한한방소아과학회[DOI]
- Do HK, "Myeonguibyeolrok", pp.165~ (1986), Inminwisaeng Publishing, Inc
- 황순이, "葎草 추출물이 Rat의 paw edema에 미치는 영향", 한방안이비인후피부과학회지, 22(3), pp.71~79 (2009), 대한한방안이비인후피부과학회
- Park SW, "Active Oxygen Scavenging Activity of Luteolin-7-O-β-D-Glucoside Isolated from Humulus japonicus", J Korean Soc Food Sci Nutr, 29(1), pp.106~110 (2000)
- 박은성, "소아 성장을 위한 한약투여에 대한 만족도와 기대치 조사", 대한한방소아과학회지, 24(1), pp.36~45 (2010), 대한한방소아과학회
- 최선희, "성장 치료를 목적으로 한방병원에 내원한 환아에 대한 임상적 고찰", 대한한방소아과학회지, 32(4), pp.51~62 (2018), 대한한방소아과학회[DOI]
- 정은진, "소아의 키 성장에 대한 성장호르몬의 치료효과", 약 학 회 지, 60(4), pp.211~221 (2016), 대한약학회
- "Global database on child growth and malnutrition" (1997)[URL]
- "Health Functional Food Functional Evaluation Guide (Related to bone health, related to joint health)" (2020)[URL]
- Jeon JK, "Normative data on serum levels of IGF-1, IGFBP-3 in healthy korean children : effect of age sex, height, body mass index, and pubertal maturation on the serum levels", J Korean Soc Pediatr Endocrinol, 5(1), pp.75~82 (2000)
- Juul A, "Growth hormone(GH)provocative retesting of 108young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I(IGF-1)and IGF-binding protein-3", J Clin Endocrinol Metab, 82(4), pp.1195~1201 (1997)
- 양기훈, "정상 어린이에서 혈청 인슐린양 성장인자-I과 인슐린양 성장인자 결합단백-2 및 -3의 농도 분석", Clinical and Experimental Pediatrics, 48(3), pp.298~305 (2005), 대한소아청소년과학회
- Kannisto S, "Biochemical markers of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy", Pediatr Res, 52(2), pp.258~262 (2002)
- Crofton PM, "Serum concentrations of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren", Clin Chem, 43(9), pp.1577~1581 (1997)
- Van Vranken M, "Evaluation of microcytosis", Am Fam Physician, 82(9), pp.1117~1122 (2010)
- "Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity" (2013)[URL]
- "Studies on Normal Values for Red Blood (RBC) by age group" (2003)[URL]
